Introduction {#Sec1}
============

γ-Aminobutyric acid type A (GABA~A~) receptors are the major inhibitory neurotransmitter receptors in the mammalian central nervous system. The GABA~A~ receptor is a pentameric protein complex, whose subunits are drawn from the following different isoforms: α(1--6), β(1--4), γ(1--3), δ, ε, θ, π and ρ(1--3). The five subunits form a chloride selective ion channel^[@CR1]--[@CR3]^. The most common isoform of this receptor consists of two α~1~, two β~2~ and one γ~2~ subunit(s)^[@CR4]--[@CR6]^ arranged α~1~γ~2~β~2~α~1~β~2~ counterclockwise when viewed from the extracellular space^[@CR7]--[@CR9]^. These receptors have two agonist GABA binding sites and one benzodiazepine binding site^[@CR10]^. By using *in vitro* mutagenesis the binding sites for the agonist GABA were located to the β~2~+/α~1~− subunit interfaces^[@CR11],[@CR12]^, and the modulatory site for benzodiazepines was at the α~1~+/γ~2~− subunit interface^[@CR13]^. Thus, the α~1~ subunit is commonly accepted to contribute to the formation of both sites.

The GABA~A~ receptors can be activated by the agonist GABA and modulated by many drugs^[@CR14]^. Among these drugs are the benzodiazepines, such as diazepam, that have sedative, anxiolytic, anticonvulsant, hypnotic, and muscle relaxant properties^[@CR15]^. Coexpression of different combinations of recombinant subunits has generated GABA~A~ receptors with distinct pharmacological and electrophysiological properties.

As early as 1990, we observed that β~2~γ~2~ GABA~A~ receptors, lacking the α~1~ subunit, were activated by GABA and potentiated by diazepam^[@CR16]^. Later this observation was confirmed by several groups for GABA and diazepam^[@CR17]--[@CR19]^ or other modulators^[@CR20]^. Expression was also documented for β~1~γ~2~ ^[@CR21],[@CR22]^ and β~3~γ~2~ ^[@CR22],[@CR23]^ GABA~A~ receptors. In the present study, we tried to understand this apparent contradiction and decided to investigate whether alternative GABA and benzodiazepine-binding subunit interfaces exist. Site-directed mutagenesis was combined with two-electrode voltage clamp in *Xenopus* oocytes. Our findings suggest that the β~2~ subunit may replace the α~1~ subunit for the formation of either site. We have previously utilized experimentally guided computational docking that led to a diazepam bound structure model at the α~1~+/γ~2~− interface^[@CR24]^. Computational docking at the β~2~+/γ~2~− interface yielded structural models which strongly suggest that diazepam can interact with this site in a binding mode nearly identical with the one observed at the canonical α~1~+/γ~2~− site, thus explaining the similar apparent potency.

Results {#Sec2}
=======

Functional expression of β~2~γ~2~ GABA~A~ receptors in *Xenopus* oocytes {#Sec3}
------------------------------------------------------------------------

We initially determined whether varying the subunit ratio led to a different extent of expression of β~2~γ~2~ GABA~A~ receptors. We injected β~2~ and γ~2~ cRNAs at the three ratios 1:1 (1 fMol each/oocyte), 2:1 (2 fMol and 1 fMol/oocyte) and 1:3 (1 fMol and 3 fMol/oocyte) into oocytes and measured the maximum current amplitudes elicited by 10 mM GABA. 5--7 days after microinjection of RNA, the β~2~γ~2~ GABA~A~ receptors formed by the 1:3 cRNA injection ratio gave the highest maximal current amplitude (131 ± 19 nA, n = 13). In contrast receptors formed from 1:1 and 2:1 cRNA ratios resulted in current amplitudes less than 100 nA. Thus, we used the 1:3 cRNA ratio coding for wild type or mutant β~2~ or γ~2~ subunits for all following experiments. Possibly the subunit arrangement is affected by the injection ratio as it has been documented in the case of β~3~γ~2~ GABA~A~ receptors^[@CR25]^. Oocytes injected with 1 fMol coding for the β~2~ subunit only, or with 3 fMol coding for the γ~2~ subunit only, both did not result in current expression.

β~2~γ~2~ receptors respond to GABA {#Sec4}
----------------------------------

5--7 days after injection, *Xenopus* oocytes expressing β~2~γ~2~ GABA~A~ receptors were investigated for the presence of currents elicited by 10 mM GABA. Figure [1a](#Fig1){ref-type="fig"} shows original current traces obtained from oocytes clamped at −80 mV. Figure [1b](#Fig1){ref-type="fig"} shows an averaged concentration-response curve for β~2~γ~2~ GABA~A~ receptors. The curve was characterized by an EC~50~ of 75 ± 5 µM and a Hill coefficient of 1.0 ± 0.1 (n = 5). This EC~50~ is similar to that reported for α~1~β~2~γ~2~, which amounts to 51 ± 15 µM^8^.Figure 1Concentration response curve for GABA at β~2~γ~2~ GABA~A~ receptors. Receptors were expressed in *Xenopus* oocytes and exposed to subsequently higher concentrations of GABA and the elicited current amplitude was determined. Individual curves were first normalized to the fitted maximal current amplitude and subsequently averaged. Data are expressed as mean ± S.E.M., n = 5 from two batches of oocytes. (**a**) Original current traces. GABA applications are indicated by a bar. The numbers indicate the concentration of GABA in μM. (**b**) Averaged concentration-response curve for β~2~γ~2~ GABA~A~ receptors. The dotted line shows for comparison corresponding data on α~1~β~2~γ~2~ GABA~A~ receptors.

β~2~γ~2~ receptors respond to diazepam {#Sec5}
--------------------------------------

Diazepam is a positive allosteric modulator of certain GABA~A~ receptors enhancing the GABA-induced chloride ion influx. We examined the current potentiation by 1 µM diazepam using a GABA concentration that elicited about 5% of the respective maximal current amplitude. Figure [2a](#Fig2){ref-type="fig"} shows original current traces from an experiment were oocytes were exposed to either GABA alone or in combination with increasing concentrations of diazepam. Figure [2b](#Fig2){ref-type="fig"} shows an averaged concentration-response curve. The curve was characterized by an EC~50~ of 69 ± 14 nM and a Hill coefficient of 0.6 ± 0.1 (n = 3). The EC~50~ is similar to that reported earlier for α~1~β~2~γ~2~ with 92 ± 6 nM^8^, while the Hill coefficient is, for reasons we do not understand, significantly lower than 1. No evidence for a possible receptor heterogeneity that could explain this finding was found (see below). Potentiation by 1 µM diazepam amounted to 216 ± 30% (n = 15).Figure 2Concentration response curve for diazepam at β~2~γ~2~ GABA~A~ receptors. Receptors were expressed in *Xenopus* oocytes and exposed to either GABA alone or GABA in the presence of subsequently higher concentrations of diazepam and the elicited current amplitude was determined. At each concentration of diazepam current potentiation was calculated. Individual curves for potentation were first normalized to the fitted maximal current amplitude and subsequently averaged. Data are expressed as mean ± S.E.M., n = 3 from two batches of oocytes. (**a**) Original current traces. (**b**) Averaged concentration-response curve for β~2~γ~2~ GABA~A~ receptors. The dotted line shows for comparison corresponding data on α~1~β~2~γ~2~ GABA~A~ receptors.

Selection of point mutations {#Sec6}
----------------------------

Obviously the α~1~ subunit is dispensable for the formation of a GABA~A~ receptor responsive to both channel agonist GABA and diazepam as shown above. We aimed to localize both binding sites in β~2~γ~2~ receptors. For this purpose we selected some point mutations that have been described to affect either the response to GABA or that to diazepam in α~1~β~2~γ~2~ ^[@CR11],[@CR12],[@CR26]--[@CR29]^ (Table [1](#Tab1){ref-type="table"}). A total of nine different point mutations were introduced into either the β~2~ subunit or γ~2~ subunit. In the β~2~ subunit we generated one mutation at the minus side (β~2~Y62L) and four mutations at the plus side (β~2~T202A, β~2~T202S, β~2~Y205S, β~2~Y205Q) and in the γ~2~ subunit one mutation on the minus side (γ~2~F77Y) and three mutations on the plus side (γ~2~S217A, γ~2~Y220S and γ~2~Y220Q). A sequence alignment of the corresponding regions in α~1~, β~2~ and γ~2~ is shown in Fig. [3](#Fig3){ref-type="fig"}. Table [1](#Tab1){ref-type="table"} summarizes the consequences of the mutations in α~1~β~2~γ~2~ receptors. In addition the effect of homologous mutations in other subunits is listed.Table 1Point mutations in β~2~ and γ~2~ used in this study.mutationeffect in α~1~β~2~γ~2~homologous residues in α~1~ or β~2~effect of homologous mutations in α~1~β~2~γ~2~Lit.β~2~Y62L30-fold decrease in EC~50~ GABAα~1~F64L200-fold decrease in EC~50~ GABA[@CR11]no shift in antagonist apparent affinity200-fold decrease in antagonist apparent affinityβ~2~T202S20-fold decrease in EC~50~ GABA(α~1~T206C)(5-fold increase in EC~50~ GABA)[@CR12],[@CR27](no effect on DZ affinity)(α~1~T206V)(7-fold decrease in DZ affinity)[@CR28]γ~2~F77Y230-fold decrease in DZ affinity[@CR29]no effect on EC~50~ GABAγ~2~S217ANot available(β~2~T202A)(drastic loss of EC~50~ GABA)[@CR12](α~1~T206A)(3-fold decrease in DZ affinity)[@CR26]γ~2~Y220QNot availableα~1~Y209Qsee above[@CR26]Point mutations were selected on the basis of previous findings in α~1~β~2~γ~2~ GABA~A~. The receptors β~2~T202Aγ~2~, β~2~Y205Sγ~2~, β~2~γ~2~Y220S and β~2~Y205Qγ~2~ were additionally studied, but were not activated by GABA or etomidate. Figure 3Sequence alignment of α~1~, β~2~ and γ~2~ subunits of the rat GABA~A~ receptor. Mutated residues of β~2~ and γ~2~ subunits are indicated with numbers. Homologous positions of the α~1~ subunit are also highlighted.

All mutated subunits were expressed in *Xenopus* oocytes in combination with wild-type subunits to result in β~2~γ~2~ GABA~A~ receptors. Functional properties were determined by using two-electrode voltage clamp.

Functional expression of receptors was verified using 50 µM etomidate as agonist since mutations affecting the response to GABA are not very likely to influence the response to this agent. Amino acid residues affecting the latter property have been described to be located within the membrane embedded part of the receptor^[@CR30]^. The mutation β~2~Y62L interfered very strongly with channel activation by etomidate. As the mutation is located far away from the suspected etomidate site^[@CR31]^, this indicates that this mutation also affects gating by etomidate (see below). Unfortunately, β~2~T202Aγ~2~, β~2~Y205Sγ~2~ and β~2~Y205Qγ~2~ all resulted in no or very little expression (Table [2](#Tab2){ref-type="table"}), so that these receptors could not be further investigated.Table 2Functional properties of expressed wild type and mutated GAB~AA~ receptor subunits.Subunit combinationEtomidate (nA; 50 µM)GABA (nA; 10 mM)EC~50~ (µM)DZ potentiation (%)Homology to mutated residuesβ~2~4 ± 1 (4)−4 ± 1 (4)---------γ~2~0 ± 0 (5)−4 ± 1 (5)---------β~2~γ~2~946 ± 8 (4)131 ± 19 (13)75 ± 5 (5)216 ± 30 (15)---β~2~Y62Lγ~2~13 ± 3 (11)53 ± 8 (17)228 ± 50 (7)121 ± 12 (5)α~1~F64, γ~2~F77β~2~T202Aγ~2~8 ± 2 (5)5 ± 0 (5)------α~1~T206, γ~2~S217β~2~T202Sγ~2~380 ± 77 (5)203 ± 18 (5)3130 ± 260 (4)100 ± 7 (4)α~1~T206, γ~2~S217β~2~Y205Sγ~2~0 ± 0 (5)0 ± 0 (16)------α~1~Y209, γ~2~Y220β~2~Y205Qγ~2~6 ± 2 (5)1 ± 0 (4)------α~1~Y209, γ~2~Y220γ~2~F77Yβ~2~193 ± 25 (4)148 ± 23 (11)72 ± 15 (5)5 ± 2 (5)α~1~F64, β~2~Y62γ~2~S217Aβ~2~141 ± 31 (5)100 ± 25 (13)133 ± 20 (3)185 ± 23 (4)α~1~T206, β~2~T202γ~2~Y220Sβ~2~76 ± 17 (5)10 ± 1 (12)------α~1~Y209, β~2~Y205γ~2~Y220Qβ~2~777 ± 113 (5)127 ± 40 (6)367 ± 139 (3)127 ± 11 (6)α~1~Y209, β~2~Y205Individual subunits or subunit combinations were expressed in *Xenopus* oocytes. Assembly of receptors was verified by determining amplitudes of current responses to 50 µM etomidate. Responses to 10 mM GABA and potentiation by 1 µM diazepam were determined.

Effect of a mutation at the plus side of β~2~ {#Sec7}
---------------------------------------------

β~2~T202S was the only investigated point mutation at the plus side of β~2~ that did not disrupt β~2~γ~2~ receptor assembly as evidenced by the large response to etomidate (Table [2](#Tab2){ref-type="table"}). In α~1~β~2~γ~2~ receptors this mutation led to a 20-fold decrease in GABA sensitivity^[@CR12]^. In β~2~γ~2~ receptors the same mutation led to a 42-fold decrease in GABA sensitivity (Fig. [4](#Fig4){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}). The EC~50~ for GABA dependent channel gating was 3130 ± 260 µM and a Hill coeffient of 0.8 ± 0.1 (n = 4). Potentiation by 1 µM diazepam was not significantly affected by the mutation (Fig. [5](#Fig5){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}).Figure 4Influence of different point mutations on the concentration dependence of GABA. Wild type or mutant β~2~γ~2~ GABA~A~ receptors were expressed in *Xenopus* oocytes and exposed to subsequently higher concentrations of GABA and the elicited current amplitude was determined. Individual curves for each subunit combination were first normalized to the fitted maximal current amplitude and subsequently averaged. Averaged concentration-response curve are shown. Data are expressed as mean ± S.E.M., n = 3--7 from two batches of oocytes. Figure 5Influence of different point mutations on the potentiation by diazepam. Receptors were expressed in *Xenopus* oocytes and first exposed to 7 µM GABA alone or the same concentration of GABA in the presence of 1 µM diazepam and the elicited current amplitude was determined. Current potentiation by diazepam was calculated and averaged for each subunit combination. Data are expressed as mean ± S.E.M., n = 4--15 from two batches of oocytes.

Effect of a mutation at the minus side of β~2~ {#Sec8}
----------------------------------------------

In α~1~β~2~γ~2~ receptors the mutation β~2~Y62L leads to a 30-fold decrease in GABA sensitivity with no effect on the antagonist affinity as compared to wild-type α~1~β~2~γ~2~ GABA~A~ receptors^[@CR11]^. The homologous mutation in the α~1~ subunit, α~1~F64L caused a 200-fold drop in both properties^[@CR11]^. Here, we found that combination of β~2~Y62L with the γ~2~ subunit showed 2-fold smaller current amplitude (Table [2](#Tab2){ref-type="table"}) as compared to wild-type β~2~γ~2~ receptors, indicating that this mutation might somehow disturb efficient assembly of functional channels and/or that gating is affected. In addition the mutation β~2~Y62L led to a 3-fold decrease in the sensitivity for GABA with an EC~50~ of 228 ± 50 µM and a Hill coefficient of 1.0 ± 0.1 (n = 7) (Fig. [4](#Fig4){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}). Again, potentiation by 1 µM diazepam was not significantly affected by the mutation (Fig. [5](#Fig5){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}).

The notion that gating is affected by the mutation is strongly supported by the fact that 50 µM etomidate elicits about 4-fold smaller currents than saturating concentrations of GABA (Table [2](#Tab2){ref-type="table"}). In wild type β~2~γ~2~ receptors this current was about 7-fold larger than the one elicited by GABA. Similarly, in mutated α~1~β~2~Y62Lγ~2~ receptors this current was about 30-fold smaller than the one elicited by GABA. As the site for etomidate is located far away from the mutated residue, this is a strong indication that β~2~Y62 is not only involved in binding of GABA, but also in gating.

Effect of mutations at the plus side of γ~2~ {#Sec9}
--------------------------------------------

Among the investigated mutations, γ~2~S217A and γ~2~Y220Q led to sizeable expression in combination with β~2~ and were further studied. To our knowledge nothing is known about both mutations. The homologous mutation to γ~2~S217A in the β~2~ subunit, β~2~T202A, led to a drastic loss in GABA sensitivity^[@CR12]^. The homologous mutation to γ~2~Y220Q in the α~1~ subunit, α~1~Y209Q, disrupted the site for diazepam, while leaving GABA sensitivity unaffected^[@CR26]^. This residue was also identified with photoaffinity labeling by the benzodiazepine binding site ligand Ro15--4513^[@CR32]^. In β~2~γ~2~S217A and β~2~γ~2~Y220Q the sensitivity to GABA was decreased 2-fold and 5-fold, respectively with EC~50s~ of 133 ± 20 µM (n = 3) and 367 ± 139 µM (n = 3), and Hill coefficients of 0.8 ± 0.1 and 0.7 ± 0.1, respectively (Fig. [4](#Fig4){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}). Potentiation by 1 µM diazepam was not significantly affected by both mutations (Fig. [5](#Fig5){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}).

Effect of a mutation at the minus side of γ~2~ {#Sec10}
----------------------------------------------

We studied the mutation γ~2~F77Y. In α~1~β~2~γ~2~ receptors this mutation abolishes the binding site for diazepam, while leaving GABA sensitivity unaffected^[@CR29]^. Similar findings were made in β~2~γ~2~ receptors. The EC~50~ for GABA was 72 ± 15 µM (n = 5) and the Hill coefficient 0.9 ± 0.1 (Fig. [4](#Fig4){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}). Modulation by 1 µM diazepam was nearly lost (Fig. [5](#Fig5){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}).

Summary of the findings {#Sec11}
-----------------------

No appreciable currents could be elicited upon expression of β~2~ or γ~2~ subunits alone and the receptors β~2~T202Aγ~2~, β~2~Y205Sγ~2~, β~2~γ~2~Y220S and β~2~Y205Qγ~2~. Modulation by diazepam was nearly lost in β~2~γ~2~F77Y receptors, whereas the reponse to GABA remained unaffected. Activation by GABA was strongly affected in β~2~T202Sγ~2~ receptors and weakly affected in β~2~Y62Lγ~2~, β~2~γ~2~S217A and β~2~γ~2~Y220Q receptors.

Computational Docking {#Sec12}
---------------------

We performed computational docking of diazepam utilizing a homology model of the β~2~+/γ~2~− interface based on the β~3~ crystal structure 4COF^[@CR33]^ as specified in the Methods section. The overal sequence similarity between β~2~+ and α~1~+ is high, especially in loops B and C where several aromatic and polar amino acids are conserved. We have shown previously that loop C residues are engaged in key interactions with diazepam^[@CR24],[@CR26]^. The docking as specified in the Methods section provided for sidechain flexibility (loops D, G, E, B and C,) as well as a limited degree of backbone flexibility in the loop C tip, very similar to the approach used in our previous docking studies at the canonical high affinity α~1~+/γ~2~− site^[@CR24]^. Computational docking usually generates correct binding poses, but they are not always correctly ranked by the different scoring functions^[@CR34]^. We therefore analyzed the top 100 poses of the docking run based on multiple different criteria: Only poses that display interactions with γ~2~F77 were considered, to limit poses to those that reflect experimental findings. Poses were then filtered by similarity to the binding mode in the high affinity α~1~+/γ~2~− site^[@CR24]^, where similarity was judged on ligand binding mode and major interactions with the pocket. Lastly, two different scoring functions were employed to identify the best candidate poses based on consensus scoring. Overall, six poses were identified that show high similarity with the high affinity binding mode at α~1~+/γ~2~−. Among these, two were found in rank one and two positions in the ChemScore ranking, and five were among top 30 ChemScored. Similarly, one of the six candidates was found in the rank two position of the GoldScore Fitness ranking, and a total of three were among the GoldScore top 30. Thus, consensus scoring leads to a binding mode model that features a binding mode very similar to the one that is observed at the canonical high affinity site.

Due to the sterically demanding sidechain β~2~F200, we find that sidechain rotamers adjust differently to ligand binding compared to the high affinity pocket, but gross binding mode and key interactions are highly similar (Fig. [6](#Fig6){ref-type="fig"}) where one of the representative poses is shown in comparison with the pose depicted in our previous study^[@CR24]^.Figure 6Structural hypothesis for diazepam binding at the extracellular β~2~+/γ~2~ interface. Panel (a) shows the reference binding pose from our previous studies^[@CR17]^ at the α~1~+ (orange)/ γ~2~− (cyan) interface. Panel (b) shows the most closely corresponding binding pose from the computational docking at the β~2~+ (red)/γ~2~− (cyan) interface. The homologous key amino acids in the binding pockets, as well as diazepam, are rendered in stick representation. While sidechain rotamers show some differences, ligand position, binding mode and key interations are very similar.

In the proposed binding mode the pendant phenyl ring is in close contact to loop A, which bears in the diazepam sensitive α isoforms a histidine, and in α~4~ and α~6~ an arginine which is known to interfere with diazepam binding^[@CR35]^. Several H101X mutations were investigated in the past, and it was demonstrated that F (Phe), Y (Tyr) or Q (Gln) have only a small impact on flunitrazepam modulation^[@CR36]^. The homologous position in β~2~ is the hydrophobic Leu99, which is sterically similar to Gln, and as hydrophobic as Phe. Thus, the proposed binding mode is compatible with previous mutagenesis studies and with the present observations.

Discussion {#Sec13}
==========

Several early studies reported responsiveness of β~2~γ~2~ GABA~A~ receptors expressed in heterologous systems to both GABA and diazepam^[@CR16]--[@CR19]^ or to GABA in β~x~γ~2~ GABA~A~ receptors^[@CR20]--[@CR23]^. Later, the two binding sites for GABA in α~1~β~2~γ~2~ GABA~A~ receptors were localized to the two β~2~+/α~1~− subunit interfaces^[@CR11],[@CR12]^ and the diazepam binding site to α~1~+/γ~2~− subunit interface^[@CR13]^. Thus, the α~1~ subunit seemed to be required for the formation of both sites. The major point of this study was to localize the subunit interfaces that harbor the alternative GABA and benzodiazepine binding sites in β~2~γ~2~ GABA~A~ receptors lacking the α~1~ subunit.

After having shown that β~2~γ~2~ GABA~A~ receptors responded similarly to GABA and diazepam as α~1~β~2~γ~2~ GABA~A~ receptors, we used point mutations abrogating one of the two in α~1~β~2~γ~2~. Unfortunately, some of the chosen mutations interfered with receptor expression or gating, presumably by negatively affecting assembly or by leading to mainly inactive channels.

The γ~2~+/β~2~− subunit interface may be excluded for both sites {#Sec14}
----------------------------------------------------------------

There are four possible subunit interfaces in β~2~γ~2~ GABA~A~ receptors: β~2~+/β~2~−, β~2~+/γ~2~−, γ~2~+/β~2~− and γ~2~+/γ~2~−. Of these, the γ~2~+/β~2~− subunit interface also occurs in the α~1~β~2~γ~2~ receptors. Mutation β~2~T202A dramatically impaired GABA activation in these receptors^[@CR12]^ and mutation α~1~Y209Q led to loss of flumazenil sensitivity^[@CR26]^. Obviously the γ~2~+/β~2~− subunit interface can not take over the formation of both sites. In addition three mutations located at this interface in β~2~γ~2~ receptors, β~2~Y62Lγ~2~, γ~2~S217Aβ~2~ and γ~2~Y220Qβ~2~, had no strong impact on the responses to GABA or diazepam (Table [2](#Tab2){ref-type="table"}). Taken together, we can exclude that the γ~2~+/β~2~− subunit interface is the location of GABA and benzodiazepine binding sites.

Localization of the diazepam binding subunit interface {#Sec15}
------------------------------------------------------

Mutations β~2~T202S^[@CR12]^ and γ~2~F77Y^[@CR29]^ have been described to disrupt GABA and diazepam binding sites in α~1~β~2~γ~2~ receptors, respectively. Mutations β~2~T202S and γ~2~F77Y similarly strongly affect the response of β~2~γ~2~ receptors to GABA and diazepam. Mutations β~2~T202S and γ~2~F77Y had little impact on diazepam and GABA sites, respectively. This implies a role of β~2~+ and γ~2~− in the formation of GABA site and diazepam site, respectively. Thus, the GABA binding site must be located at β~2~+/β~2~− or β~2~+/γ~2~− subunit interfaces and that for diazepam at β~2~+/γ~2~− or γ~2~+/γ~2~−.

The mutation α~1~Y209Q abrogates the diazepam site in α~1~β~2~γ~2~ receptors^[@CR26]^. Therefore, it may be expected that the homologous mutation in the γ~2~ subunit, γ~2~Y220Q, affects the apparent affinity for diazepam. Similarly, the mutation α~1~T206A decreases the affinity for diazepam in α~1~β~2~γ~2~ receptors^[@CR26]^. Thus, it may be expected that the homologous mutation in the γ~2~ subunit, γ~2~S217A, affects the apparent affinity for diazepam. Both mutations failed to affect the response to diazepam, arguing strongly against involvement of the γ~2~+ subunit interface in the diazepam site. For these reasons, we locate this site to the β~2~+/γ~2~− subunit interface (Fig. [7](#Fig7){ref-type="fig"}). The failure of the mutation β~2~T202S to affect the response to diazepam may be explained by the fact that a homologous, similar mutation α~1~T206C did not affect the response to diazepam in α~1~β~2~γ~2~ receptors^[@CR27]^. The high affinity interaction of diazepam with the β~2~+/γ~2~− subunit interface is also supported by the docking experiments (Fig. [6](#Fig6){ref-type="fig"}), which strongly suggest that diazepam binds in this non-canonical site in a fashion very similar to the one that is observed in the high affinity site.Figure 7Schematic representation of β~2~γ~2~ GABA~A~ receptors. The location of amino acid residues of interest is indicated. Point mutations resulting in disrupting assembly are not shown. The binding site for GABA is concluded to locate at the β~2~+/ β~2~− interface, that for diazepam at the β~2~+/γ~2~− interface. Please note that the subunit arrangement was not addressed in this study.

Putative localization of the GABA binding subunit interface {#Sec16}
-----------------------------------------------------------

Thus, we are left with the β~2~+/β~2~− and the γ~2~+/γ~2~− subunit interfaces. The mutation β~2~T202S at the β~2~+ has very strong effect on the EC~50~ for GABA shifting the concentration response curve 42-fold, while effects of mutations at the γ~2~+ side are much smaller. Therefore we localize the GABA binding site at the β~2~+/β~2~− subunit interface (Fig. [7](#Fig7){ref-type="fig"}). However, we can not fully exclude an additional site at a γ~2~+ side. As β~2~+/γ~2~− has been excluded, this additional GABA site would have to be at the γ~2~+/γ~2~− interface. It should be noted that a binding site for GABA has also been described at the β~3~+/δ− subunit interface^[@CR37]^.

Functional expression {#Sec17}
---------------------

We observed that individual β~2~ or γ~2~ subunits did not form functional receptors on the surface of oocytes. Within 1 day after injection, the α~1~β~2~γ~2~ receptors expressed currents in µA range^[@CR38]^. In contrast, we observed in this work that the β~2~γ~2~ receptors need longer period for channel expession (5--7 days) and the maximal current amplitudes elicited by 10 mM GABA amount to only 100--200 nA. If silent receptors and different single channel open frequency between receptors are ignored, β~2~γ~2~ receptors form less efficiently than α~1~β~2~γ~2~ receptors. A previous study described a important role of α~1~ subunits for receptor trafficking and assembly in α~1~β~2~γ~2~ receptors^[@CR39]^. Thus, in the presence of large amounts of α~1~, β~2~γ~2~ may not be formed. Under special circumstances where α subunit expression is low, the formation of a limited amount of β~2~γ~2~ receptors may occur. Recent single cell RT-PCR data indicate that cells devoid of mRNA coding for α subunits are not present in the hypothalamus, where diversity of neurons is huge. However, the endocrine system may have receptors without α subunits. Chromaffine cells (at least in certain developmental stages) have only mRNA coding for β~3~ and ε subunits (personal communication, I. Adameyko).

While so far it is not considered a candidate receptor to exist in the adult mammalian nervous system, the possible existence of such receptors has also not been specifically excluded. Given that fact that in the developing mammalian brain expression of all three γ isoforms is higher than in the postnatal brain, non-canonical receptor arrangements should be considered. In this vein, it is very important to realize that a high affinity benzodiazepine binding site at the β~2~+/γ~2~− interface implies that such receptors cannot be distinguished from α+/γ~2~− "canonical" receptors in radioligand and PET studies where benzodiazepine ligands are used as presumably selective probes for α+/γ~2~− canonical benzodiazepine-sites.

What may be the biological relevance of our observations? Ralvenius *et al*.^[@CR40]^ studied mice carrying a point mutation in all those four alpha subunits that can form diazepam sensitive GABA~A~ receptors. At 10 mg/kg diazepam these mice were completely protected from diazepam-induced muscle relaxation and motor impairment. However, they showed a trend towards reduced locomotor activity that was quite prominent at higher doses. At least part of this response could be due to β~2~γ~2~ GABA~A~ receptors. We have not tested whether β~1~ or β~3~ (that may form β~1~γ~2~ and β~3~γ~2~) behave as β~2~. As their loop C differs (see Supplementary Fig. [S1](#MOESM1){ref-type="media"}), it is conceivable that the diazepam site described here does not exist or has different properties in these receptors.

Summary {#Sec18}
-------

While in α~1~β~2~γ~2~ receptors diazepam binds to the α~1~+/γ~2~− subunit interface and GABA to β~2~+/α~1~−, in β~2~γ~2~ receptors diazepam binds to the β~2~+/γ~2~− subunit interface and GABA to β~2~+/β~2~− (Fig. [7](#Fig7){ref-type="fig"}). Thus, the β~2~ subunit can take over the role of the α~1~ subunit for the formation of both sites, its minus side for the GABA binding site and its plus side for the diazepam binding site.

Methods {#Sec19}
=======

Construction of mutated receptor subunits {#Sec20}
-----------------------------------------

The point mutations β~2~Y62Lγ~2~, β~2~T202Aγ~2~, β~2~T202Sγ~2~, β~2~Y205Sγ~2~, β~2~Y205Qγ~2~, β~2~γ~2~F77Y, β~2~γ~2~S217A, β~2~γ~2~Y220S and β~2~γ~2~Y220Q were prepared using the QuickChange^TM^ mutagenesis kit (Stratagene, Agilent Technologies, Basel, Switzerland).

Expression in *Xenopus* oocytes {#Sec21}
-------------------------------

Animal experiments were carried out in strict accordance to the Swiss ethical guidelines, and have been approved by the local committee of the Canton Bern Kantonstierarzt, Kantonaler Veterinärdienst Bern (BE85/15). Surgery of *Xenopus laevis* to obtain the oocytes was done under anesthesia, and all efforts were made to diminish animal suffering. Oocytes were prepared, injected and defolliculated as described previously^[@CR41],[@CR42]^. Polyadenylated cRNA coding for the subunits of GABA~A~ receptors were prepared *in vitro* with the mMESSAGE mMACHINE kit (Ambion, Austin, TX, USA). Oocytes were injected with 50 nl of solution containing cRNA coding for wild type or mutants β~2~ (1 fMol) or γ~2~ (3 fMol) subunits and then incubated in modified Barth's solution (10 mM HEPES, pH 7.5, 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO~3~, 0.82 mM MgSO~4~, 0.34 mM Ca(NO~3~)~2~, 0.41 mM CaCl~2~, 100 units/ml penicillin, 100 µg/ml streptomycin) at 18 °C for 5--7 days before measurements.

Functional characterization in *Xenopus* oocytes {#Sec22}
------------------------------------------------

Electrophysiological experiments were performed using an Oocyte Clamp OC-725 (Warner Instrument Corp., Hamden, USA) two-electrode voltage clamp amplifier. Currents were digitized at 5 kHz with MacLab/200 (AD Instruments, Spechbach, Germany).

The holding potential was −80 mV. The perfusion medium contained 90 mM NaCl, 1 mM KCl, 1 mM MgCl~2~, 1 mM CaCl~2~ and 5 mM Na-HEPES (pH 7.4). The perfusion solution (6 ml/min) was applied through a glass capillary with an inner diameter of 1.35 mm, the mouth of which was placed about 0.5 mm from the surface of the oocyte. Individual concentration response curves for GABA were fitted with the equation I(c) = I~max~/\[1 + (EC~50~/c)^n^\], where c is the concentration of GABA, EC~50~ the concentration of GABA eliciting half-maximal current amplitude, I~max~ is the maximal current amplitude, I is the current amplitude, and n is the Hill coefficient. Maximal current amplitudes (I~max~) were obtained from the fits of the concentration-response curves. The individual curves were fitted and standardized to I~max~ and subsequently averaged. For all receptors studied, potentiation was measured at a GABA concentration eliciting 1--5% of the maximal GABA current amplitude. GABA was applied twice alone for 20 s, and then in combination with diazepam for 20 s. The duration of washout periods was 4 min in between agonist or agonist/drug applications to prevent receptor desensitization. At the beginning of the experiments, GABA applications were repeated when the elicited current amplitude altered by \>5%. Potentiation was calculated by the following equation: (I~Modulator + GABA~/I~GABA~−1) \* 100%. Concentration dependent potentiation was fitted with the equation I(c) = I~max~/\[1 + (EC~50~/c)^n^\], where c is the concentration of diazepam, EC~50~ the concentration of diazepam eliciting half-maximal current amplitude, I~max~ is the maximal current amplitude, I is the current amplitude, and n is the Hill coefficient. Maximal current amplitudes (I~max~) were obtained from the fits of the concentration-response curves. The individual curves were fitted and standardized to I~max~ and subsequently averaged.

All data are from at least two different batches of oocytes. Data represent mean ± S.E.M as indicated in each case. An unpaired *t-test* was used to compare two means. \*\*\*p \< 0.001.

Computational Modelling and Docking {#Sec23}
-----------------------------------

Homology models of the β~2~+/γ~2~− interface were generated based on the 4COF GABA~A~ receptors human β~3~ homopentamer structure^[@CR24]^. Due to the high homology of the β~2~ and β~3~ subunits, no insertions or deletions requiring gaps occur in the extracellular domain, while an alignment of the γ~2~ subunit as described previously^[@CR43]^ was used to account for the lower homology in the loop F region. Computational docking was subsequently performed using the GOLD software v1.6.2^[@CR44]^, where the binding site was defined to be at the interface between loops A -- G of the subunits. Sidechains β~2~Y157, β~2~T160, β~2~Y159, β~2~T161, β~2~F200, β~2~T202, and β~2~Y205 as well as γ~2~Y58, γ~2~F77 and γ~2~T142 were kept flexible, soft potential were applied to the tip of loop C (β~2~V198 - β~2~G203) to allow some degree of backbone flexibility, default settings for the docking run were used and the top 100 ranked poses were retained for subsequent analysis. Ligand interactions of poses were computed using the MOE program (MOE (The Molecular Operating Environment), Version 2011.10, Chemical Computing Group Inc., Montreal), and poses featuring interactions with γ~2~F77 were inspected using two scoring functions (ChemScore Fitness as implemented in GOLD, GoldScore Fitness). "Hits" were defined as poses among top 30 ranked in both scoring functions (consensus score hits) and featuring interactions with γ~2~F77 and the resulting hit poses were subsequently compared to our poses from previous work at the canonical binding site^[@CR24]^.

Data availability {#Sec24}
-----------------

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
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